SCHEMBL19731968

SCHEMBL19731968

Cc1ccc2nc3n(-c4ccc5oc6ccc(-c7ccc8oc9ccc(-n%10c%11ccccc%11n%11c%12ccccc%12nc%10%11)cc9c8c7)cc6c5c4)c4ccccc4n3c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35
GABRQ Q9UN88 1/20 0.35
HPGD P15428 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 3/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17993474 0.94 HPGD (0.38) HPGDSMN1; SMN2KDM4EPOLBNPC1
SCHEMBL17993513 0.92 TP53 (0.38) HPGDSMN1; SMN2KDM4EPOLBNPC1
SCHEMBL12800986 0.91 GABRP (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12800969 0.91 CHEK2 (0.33) HPGDSMN1; SMN2KDM4EPOLBNPC1
SCHEMBL19521865 0.91 KDM4E (0.36) HPGDSMN1; SMN2KDM4EPOLBNPC1
SCHEMBL19275393 0.90 PDE10A (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL21412960 0.90 HPGD (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16388451 0.88 ALDH1A1 (0.33) HPGDSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL16920073 0.87 PDE10A (0.35) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12800967 0.87 CHEK2 (0.33) HPGDSMN1; SMN2KDM4EPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362241-A1 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) IDEMITSU KOSAN CO., LTD. (JP) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362241-A1 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) OCIAD1, OCIAD2, DDT GABRP 3199/4885GABRD 1376/4885GABRA1 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.